nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Gemcitabine—urinary bladder cancer	0.282	1	CrCtD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—urinary bladder cancer	0.207	0.515	CiPCiCtD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—urinary bladder cancer	0.194	0.485	CiPCiCtD
Azacitidine—CDA—Gemcitabine—urinary bladder cancer	0.132	1	CbGbCtD
Azacitidine—Cytarabine—Gemcitabine—urinary bladder cancer	0.0568	0.525	CrCrCtD
Azacitidine—Decitabine—Gemcitabine—urinary bladder cancer	0.0514	0.475	CrCrCtD
Azacitidine—CDA—Pyrimidine salvage reactions—TYMP—urinary bladder cancer	0.00294	0.135	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—S100A7—urinary bladder cancer	0.00186	0.0854	CbGpPWpGaD
Azacitidine—DNMT3A—prostate gland—urinary bladder cancer	0.00164	0.13	CbGeAlD
Azacitidine—CDA—prostate gland—urinary bladder cancer	0.00155	0.123	CbGeAlD
Azacitidine—DNMT3A—seminal vesicle—urinary bladder cancer	0.00138	0.11	CbGeAlD
Azacitidine—CDA—Pyrimidine metabolism—TYMP—urinary bladder cancer	0.00134	0.0616	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00104	0.0478	CbGpPWpGaD
Azacitidine—DNMT1—prostate gland—urinary bladder cancer	0.00099	0.0785	CbGeAlD
Azacitidine—DNMT3A—female reproductive system—urinary bladder cancer	0.000893	0.0708	CbGeAlD
Azacitidine—DNMT1—seminal vesicle—urinary bladder cancer	0.000837	0.0664	CbGeAlD
Azacitidine—CDA—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000812	0.0373	CbGpPWpGaD
Azacitidine—DNMT3A—vagina—urinary bladder cancer	0.000808	0.0641	CbGeAlD
Azacitidine—CDA—vagina—urinary bladder cancer	0.000764	0.0605	CbGeAlD
Azacitidine—DNMT1—epithelium—urinary bladder cancer	0.000727	0.0577	CbGeAlD
Azacitidine—DNMT3A—RMTs methylate histone arginines—ARID1A—urinary bladder cancer	0.000672	0.0308	CbGpPWpGaD
Azacitidine—DNMT1—urethra—urinary bladder cancer	0.000663	0.0525	CbGeAlD
Azacitidine—CDA—Pyrimidine metabolism—TYMS—urinary bladder cancer	0.000607	0.0279	CbGpPWpGaD
Azacitidine—DNMT3A—One Carbon Metabolism—TYMS—urinary bladder cancer	0.000559	0.0257	CbGpPWpGaD
Azacitidine—DNMT1—female reproductive system—urinary bladder cancer	0.00054	0.0428	CbGeAlD
Azacitidine—CDA—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000523	0.024	CbGpPWpGaD
Azacitidine—DNMT3A—lymph node—urinary bladder cancer	0.000523	0.0414	CbGeAlD
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—TYMS—urinary bladder cancer	0.000503	0.0231	CbGpPWpGaD
Azacitidine—CDA—lymph node—urinary bladder cancer	0.000494	0.0392	CbGeAlD
Azacitidine—DNMT3A—One Carbon Metabolism—MTHFR—urinary bladder cancer	0.000489	0.0224	CbGpPWpGaD
Azacitidine—DNMT1—vagina—urinary bladder cancer	0.000489	0.0387	CbGeAlD
Azacitidine—CDA—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.00047	0.0216	CbGpPWpGaD
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—MTHFR—urinary bladder cancer	0.000439	0.0202	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000437	0.0201	CbGpPWpGaD
Azacitidine—Cytarabine—POLB—urinary bladder cancer	0.000425	0.276	CrCbGaD
Azacitidine—CDA—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000411	0.0189	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000408	0.0187	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—KDM6A—urinary bladder cancer	0.000379	0.0174	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—TYMS—urinary bladder cancer	0.000378	0.0173	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—TYMS—urinary bladder cancer	0.00034	0.0156	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—MTHFR—urinary bladder cancer	0.00033	0.0152	CbGpPWpGaD
Azacitidine—DNMT1—lymph node—urinary bladder cancer	0.000316	0.0251	CbGeAlD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—MTHFR—urinary bladder cancer	0.000297	0.0136	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ARID1A—urinary bladder cancer	0.000287	0.0132	CbGpPWpGaD
Azacitidine—Clofarabine—RRM2—urinary bladder cancer	0.000271	0.176	CrCbGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—RRM2—urinary bladder cancer	0.000264	0.0121	CbGpPWpGaD
Azacitidine—Gemcitabine—RRM2—urinary bladder cancer	0.000248	0.161	CrCbGaD
Azacitidine—CDA—Nucleotide metabolism—TYMS—urinary bladder cancer	0.000236	0.0108	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000224	0.0103	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000224	0.0103	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CDK4—urinary bladder cancer	0.000198	0.0091	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCNE1—urinary bladder cancer	0.000194	0.0089	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—ERBB2—urinary bladder cancer	0.000167	0.00765	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—ERCC2—urinary bladder cancer	0.00016	0.00735	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000156	0.00716	CbGpPWpGaD
Azacitidine—Cladribine—RRM2—urinary bladder cancer	0.000156	0.101	CrCbGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	0.000155	0.00713	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TYMS—urinary bladder cancer	0.000153	0.007	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDK4—urinary bladder cancer	0.000148	0.00681	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—urinary bladder cancer	0.000147	0.00676	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1A—urinary bladder cancer	0.000142	0.00654	CbGpPWpGaD
Azacitidine—Glucosamine—MMP9—urinary bladder cancer	0.00014	0.0913	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—EP300—urinary bladder cancer	0.000136	0.00622	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—PPARG—urinary bladder cancer	0.000135	0.00619	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CREBBP—urinary bladder cancer	0.00013	0.00595	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—RB1—urinary bladder cancer	0.000129	0.00592	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CCND1—urinary bladder cancer	0.000128	0.00588	CbGpPWpGaD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—ERCC2—urinary bladder cancer	0.000125	0.00573	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—ERCC2—urinary bladder cancer	0.000122	0.0056	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.000119	0.00546	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—urinary bladder cancer	0.000118	0.00542	CbGpPWpGaD
Azacitidine—Gemcitabine—TYMS—urinary bladder cancer	0.000117	0.0758	CrCbGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—urinary bladder cancer	0.000113	0.00521	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—ERCC2—urinary bladder cancer	0.000108	0.00497	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—NCOR1—urinary bladder cancer	0.000107	0.00493	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.000103	0.00475	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND1—urinary bladder cancer	9.58e-05	0.0044	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN1A—urinary bladder cancer	9.27e-05	0.00426	CbGpPWpGaD
Azacitidine—Glucosamine—TNF—urinary bladder cancer	9.22e-05	0.06	CrCbGaD
Azacitidine—Adenosine monophosphate—SRC—urinary bladder cancer	8.9e-05	0.0579	CrCbGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—EP300—urinary bladder cancer	8.82e-05	0.00405	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CDK4—urinary bladder cancer	8.48e-05	0.00389	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTZ1—urinary bladder cancer	8.27e-05	0.0038	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTO2—urinary bladder cancer	7.84e-05	0.0036	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NAT1—urinary bladder cancer	7.84e-05	0.0036	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	7.68e-05	0.00353	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	7.43e-05	0.00341	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CREBBP—urinary bladder cancer	7.4e-05	0.0034	CbGpPWpGaD
Azacitidine—CDA—Metabolism—UGT2B7—urinary bladder cancer	7.17e-05	0.00329	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP4B1—urinary bladder cancer	6.46e-05	0.00296	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	6.16e-05	0.00283	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC19A1—urinary bladder cancer	6.1e-05	0.0028	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PRSS3—urinary bladder cancer	5.94e-05	0.00273	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CCND1—urinary bladder cancer	5.47e-05	0.00251	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	5.06e-05	0.00232	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—EP300—urinary bladder cancer	5.04e-05	0.00231	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TYMP—urinary bladder cancer	4.75e-05	0.00218	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NAT2—urinary bladder cancer	4.3e-05	0.00197	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—SMC1A—urinary bladder cancer	4.23e-05	0.00194	CbGpPWpGaD
Azacitidine—CDA—Metabolism—RRM2—urinary bladder cancer	3.71e-05	0.0017	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ESR2—urinary bladder cancer	3.69e-05	0.00169	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HPGDS—urinary bladder cancer	3.43e-05	0.00158	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ENO2—urinary bladder cancer	3.43e-05	0.00158	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTT1—urinary bladder cancer	3.33e-05	0.00153	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—SMC1A—urinary bladder cancer	2.86e-05	0.00131	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NCOR1—urinary bladder cancer	2.85e-05	0.00131	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NQO1—urinary bladder cancer	2.77e-05	0.00127	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ERCC2—urinary bladder cancer	2.68e-05	0.00123	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ESR2—urinary bladder cancer	2.49e-05	0.00114	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTP1—urinary bladder cancer	2.31e-05	0.00106	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ESR1—urinary bladder cancer	2.24e-05	0.00103	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TYMS—urinary bladder cancer	2.15e-05	0.000986	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GSTM1—urinary bladder cancer	2.12e-05	0.000974	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NCOR1—urinary bladder cancer	2.12e-05	0.000974	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PPARG—urinary bladder cancer	2.04e-05	0.000936	CbGpPWpGaD
Azacitidine—Nausea—Thiotepa—urinary bladder cancer	2.04e-05	0.000505	CcSEcCtD
Azacitidine—Urethral disorder—Methotrexate—urinary bladder cancer	2.04e-05	0.000505	CcSEcCtD
Azacitidine—Weight decreased—Doxorubicin—urinary bladder cancer	2.03e-05	0.000504	CcSEcCtD
Azacitidine—CDA—Metabolism—GPX1—urinary bladder cancer	2.03e-05	0.000933	CbGpPWpGaD
Azacitidine—Sinusitis—Epirubicin—urinary bladder cancer	2.03e-05	0.000503	CcSEcCtD
Azacitidine—Feeling abnormal—Etoposide—urinary bladder cancer	2.03e-05	0.000503	CcSEcCtD
Azacitidine—Agranulocytosis—Epirubicin—urinary bladder cancer	2.02e-05	0.000501	CcSEcCtD
Azacitidine—Pneumonia—Doxorubicin—urinary bladder cancer	2.02e-05	0.000499	CcSEcCtD
Azacitidine—Gastrointestinal pain—Etoposide—urinary bladder cancer	2.01e-05	0.000499	CcSEcCtD
Azacitidine—Pruritus—Fluorouracil—urinary bladder cancer	2.01e-05	0.000497	CcSEcCtD
Azacitidine—Infestation—Doxorubicin—urinary bladder cancer	2e-05	0.000496	CcSEcCtD
Azacitidine—Infestation NOS—Doxorubicin—urinary bladder cancer	2e-05	0.000496	CcSEcCtD
Azacitidine—CDA—Metabolism—ERCC2—urinary bladder cancer	2e-05	0.000916	CbGpPWpGaD
Azacitidine—Hypersensitivity—Cisplatin—urinary bladder cancer	1.98e-05	0.000491	CcSEcCtD
Azacitidine—Diarrhoea—Gemcitabine—urinary bladder cancer	1.97e-05	0.000489	CcSEcCtD
Azacitidine—Renal failure—Doxorubicin—urinary bladder cancer	1.97e-05	0.000488	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—CREBBP—urinary bladder cancer	1.96e-05	0.0009	CbGpPWpGaD
Azacitidine—Urticaria—Etoposide—urinary bladder cancer	1.96e-05	0.000485	CcSEcCtD
Azacitidine—Haemoglobin—Epirubicin—urinary bladder cancer	1.95e-05	0.000484	CcSEcCtD
Azacitidine—Stomatitis—Doxorubicin—urinary bladder cancer	1.95e-05	0.000484	CcSEcCtD
Azacitidine—Rhinitis—Epirubicin—urinary bladder cancer	1.95e-05	0.000483	CcSEcCtD
Azacitidine—Abdominal pain—Etoposide—urinary bladder cancer	1.95e-05	0.000483	CcSEcCtD
Azacitidine—Body temperature increased—Etoposide—urinary bladder cancer	1.95e-05	0.000483	CcSEcCtD
Azacitidine—Urinary tract infection—Doxorubicin—urinary bladder cancer	1.95e-05	0.000483	CcSEcCtD
Azacitidine—Haemorrhage—Epirubicin—urinary bladder cancer	1.94e-05	0.000482	CcSEcCtD
Azacitidine—Eye disorder—Methotrexate—urinary bladder cancer	1.94e-05	0.000481	CcSEcCtD
Azacitidine—Diarrhoea—Fluorouracil—urinary bladder cancer	1.94e-05	0.000481	CcSEcCtD
Azacitidine—Hypoaesthesia—Epirubicin—urinary bladder cancer	1.93e-05	0.000479	CcSEcCtD
Azacitidine—Asthenia—Cisplatin—urinary bladder cancer	1.93e-05	0.000478	CcSEcCtD
Azacitidine—Pharyngitis—Epirubicin—urinary bladder cancer	1.93e-05	0.000478	CcSEcCtD
Azacitidine—Cardiac disorder—Methotrexate—urinary bladder cancer	1.93e-05	0.000478	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—NCOR1—urinary bladder cancer	1.92e-05	0.000883	CbGpPWpGaD
Azacitidine—Urinary tract disorder—Epirubicin—urinary bladder cancer	1.92e-05	0.000476	CcSEcCtD
Azacitidine—Oedema peripheral—Epirubicin—urinary bladder cancer	1.92e-05	0.000475	CcSEcCtD
Azacitidine—Haematuria—Doxorubicin—urinary bladder cancer	1.91e-05	0.000473	CcSEcCtD
Azacitidine—Connective tissue disorder—Epirubicin—urinary bladder cancer	1.91e-05	0.000473	CcSEcCtD
Azacitidine—Urethral disorder—Epirubicin—urinary bladder cancer	1.91e-05	0.000472	CcSEcCtD
Azacitidine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	1.9e-05	0.00047	CcSEcCtD
Azacitidine—Epistaxis—Doxorubicin—urinary bladder cancer	1.89e-05	0.000468	CcSEcCtD
Azacitidine—Angiopathy—Methotrexate—urinary bladder cancer	1.88e-05	0.000467	CcSEcCtD
Azacitidine—Sinusitis—Doxorubicin—urinary bladder cancer	1.88e-05	0.000466	CcSEcCtD
Azacitidine—Immune system disorder—Methotrexate—urinary bladder cancer	1.88e-05	0.000465	CcSEcCtD
Azacitidine—Dizziness—Fluorouracil—urinary bladder cancer	1.88e-05	0.000465	CcSEcCtD
Azacitidine—CDA—Metabolism—MTHFR—urinary bladder cancer	1.88e-05	0.000861	CbGpPWpGaD
Azacitidine—Mediastinal disorder—Methotrexate—urinary bladder cancer	1.87e-05	0.000464	CcSEcCtD
Azacitidine—Agranulocytosis—Doxorubicin—urinary bladder cancer	1.87e-05	0.000463	CcSEcCtD
Azacitidine—Chills—Methotrexate—urinary bladder cancer	1.86e-05	0.000462	CcSEcCtD
Azacitidine—Diarrhoea—Cisplatin—urinary bladder cancer	1.84e-05	0.000456	CcSEcCtD
Azacitidine—Alopecia—Methotrexate—urinary bladder cancer	1.84e-05	0.000455	CcSEcCtD
Azacitidine—Vomiting—Gemcitabine—urinary bladder cancer	1.83e-05	0.000455	CcSEcCtD
Azacitidine—Mental disorder—Methotrexate—urinary bladder cancer	1.82e-05	0.000451	CcSEcCtD
Azacitidine—Rash—Gemcitabine—urinary bladder cancer	1.82e-05	0.000451	CcSEcCtD
Azacitidine—Dermatitis—Gemcitabine—urinary bladder cancer	1.82e-05	0.00045	CcSEcCtD
Azacitidine—Eye disorder—Epirubicin—urinary bladder cancer	1.82e-05	0.00045	CcSEcCtD
Azacitidine—Hypersensitivity—Etoposide—urinary bladder cancer	1.82e-05	0.00045	CcSEcCtD
Azacitidine—Malnutrition—Methotrexate—urinary bladder cancer	1.81e-05	0.000448	CcSEcCtD
Azacitidine—Erythema—Methotrexate—urinary bladder cancer	1.81e-05	0.000448	CcSEcCtD
Azacitidine—Haemoglobin—Doxorubicin—urinary bladder cancer	1.81e-05	0.000448	CcSEcCtD
Azacitidine—Headache—Gemcitabine—urinary bladder cancer	1.81e-05	0.000448	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—ERCC2—urinary bladder cancer	1.81e-05	0.00083	CbGpPWpGaD
Azacitidine—Cardiac disorder—Epirubicin—urinary bladder cancer	1.8e-05	0.000447	CcSEcCtD
Azacitidine—Vomiting—Fluorouracil—urinary bladder cancer	1.8e-05	0.000447	CcSEcCtD
Azacitidine—Rhinitis—Doxorubicin—urinary bladder cancer	1.8e-05	0.000447	CcSEcCtD
Azacitidine—Haemorrhage—Doxorubicin—urinary bladder cancer	1.8e-05	0.000446	CcSEcCtD
Azacitidine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	1.79e-05	0.000443	CcSEcCtD
Azacitidine—Rash—Fluorouracil—urinary bladder cancer	1.79e-05	0.000443	CcSEcCtD
Azacitidine—Dermatitis—Fluorouracil—urinary bladder cancer	1.79e-05	0.000443	CcSEcCtD
Azacitidine—Pharyngitis—Doxorubicin—urinary bladder cancer	1.79e-05	0.000442	CcSEcCtD
Azacitidine—Headache—Fluorouracil—urinary bladder cancer	1.78e-05	0.00044	CcSEcCtD
Azacitidine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	1.78e-05	0.00044	CcSEcCtD
Azacitidine—Oedema peripheral—Doxorubicin—urinary bladder cancer	1.77e-05	0.000439	CcSEcCtD
Azacitidine—Asthenia—Etoposide—urinary bladder cancer	1.77e-05	0.000438	CcSEcCtD
Azacitidine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	1.77e-05	0.000438	CcSEcCtD
Azacitidine—Angiopathy—Epirubicin—urinary bladder cancer	1.76e-05	0.000437	CcSEcCtD
Azacitidine—Urethral disorder—Doxorubicin—urinary bladder cancer	1.76e-05	0.000437	CcSEcCtD
Azacitidine—Immune system disorder—Epirubicin—urinary bladder cancer	1.76e-05	0.000435	CcSEcCtD
Azacitidine—Mediastinal disorder—Epirubicin—urinary bladder cancer	1.75e-05	0.000434	CcSEcCtD
Azacitidine—Back pain—Methotrexate—urinary bladder cancer	1.75e-05	0.000433	CcSEcCtD
Azacitidine—Chills—Epirubicin—urinary bladder cancer	1.74e-05	0.000432	CcSEcCtD
Azacitidine—Pruritus—Etoposide—urinary bladder cancer	1.74e-05	0.000432	CcSEcCtD
Azacitidine—Alopecia—Epirubicin—urinary bladder cancer	1.72e-05	0.000426	CcSEcCtD
Azacitidine—Nausea—Gemcitabine—urinary bladder cancer	1.71e-05	0.000425	CcSEcCtD
Azacitidine—Vomiting—Cisplatin—urinary bladder cancer	1.71e-05	0.000424	CcSEcCtD
Azacitidine—Mental disorder—Epirubicin—urinary bladder cancer	1.7e-05	0.000422	CcSEcCtD
Azacitidine—Rash—Cisplatin—urinary bladder cancer	1.7e-05	0.00042	CcSEcCtD
Azacitidine—Dermatitis—Cisplatin—urinary bladder cancer	1.69e-05	0.00042	CcSEcCtD
Azacitidine—Erythema—Epirubicin—urinary bladder cancer	1.69e-05	0.000419	CcSEcCtD
Azacitidine—Malnutrition—Epirubicin—urinary bladder cancer	1.69e-05	0.000419	CcSEcCtD
Azacitidine—Diarrhoea—Etoposide—urinary bladder cancer	1.69e-05	0.000418	CcSEcCtD
Azacitidine—Nausea—Fluorouracil—urinary bladder cancer	1.69e-05	0.000418	CcSEcCtD
Azacitidine—Eye disorder—Doxorubicin—urinary bladder cancer	1.68e-05	0.000417	CcSEcCtD
Azacitidine—Ill-defined disorder—Methotrexate—urinary bladder cancer	1.68e-05	0.000416	CcSEcCtD
Azacitidine—Anaemia—Methotrexate—urinary bladder cancer	1.67e-05	0.000414	CcSEcCtD
Azacitidine—Cardiac disorder—Doxorubicin—urinary bladder cancer	1.67e-05	0.000414	CcSEcCtD
Azacitidine—Back pain—Epirubicin—urinary bladder cancer	1.64e-05	0.000406	CcSEcCtD
Azacitidine—Angiopathy—Doxorubicin—urinary bladder cancer	1.63e-05	0.000404	CcSEcCtD
Azacitidine—Malaise—Methotrexate—urinary bladder cancer	1.63e-05	0.000404	CcSEcCtD
Azacitidine—Dizziness—Etoposide—urinary bladder cancer	1.63e-05	0.000404	CcSEcCtD
Azacitidine—Muscle spasms—Epirubicin—urinary bladder cancer	1.63e-05	0.000403	CcSEcCtD
Azacitidine—Immune system disorder—Doxorubicin—urinary bladder cancer	1.62e-05	0.000403	CcSEcCtD
Azacitidine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	1.62e-05	0.000402	CcSEcCtD
Azacitidine—Leukopenia—Methotrexate—urinary bladder cancer	1.62e-05	0.000401	CcSEcCtD
Azacitidine—Chills—Doxorubicin—urinary bladder cancer	1.61e-05	0.0004	CcSEcCtD
Azacitidine—Nausea—Cisplatin—urinary bladder cancer	1.6e-05	0.000396	CcSEcCtD
Azacitidine—Alopecia—Doxorubicin—urinary bladder cancer	1.59e-05	0.000394	CcSEcCtD
Azacitidine—Cough—Methotrexate—urinary bladder cancer	1.58e-05	0.000391	CcSEcCtD
Azacitidine—Mental disorder—Doxorubicin—urinary bladder cancer	1.58e-05	0.00039	CcSEcCtD
Azacitidine—Ill-defined disorder—Epirubicin—urinary bladder cancer	1.57e-05	0.000389	CcSEcCtD
Azacitidine—Convulsion—Methotrexate—urinary bladder cancer	1.57e-05	0.000388	CcSEcCtD
Azacitidine—Vomiting—Etoposide—urinary bladder cancer	1.57e-05	0.000388	CcSEcCtD
Azacitidine—Malnutrition—Doxorubicin—urinary bladder cancer	1.57e-05	0.000388	CcSEcCtD
Azacitidine—Erythema—Doxorubicin—urinary bladder cancer	1.57e-05	0.000388	CcSEcCtD
Azacitidine—Anaemia—Epirubicin—urinary bladder cancer	1.56e-05	0.000388	CcSEcCtD
Azacitidine—Rash—Etoposide—urinary bladder cancer	1.55e-05	0.000385	CcSEcCtD
Azacitidine—Dermatitis—Etoposide—urinary bladder cancer	1.55e-05	0.000385	CcSEcCtD
Azacitidine—Headache—Etoposide—urinary bladder cancer	1.54e-05	0.000382	CcSEcCtD
Azacitidine—Myalgia—Methotrexate—urinary bladder cancer	1.54e-05	0.000381	CcSEcCtD
Azacitidine—Chest pain—Methotrexate—urinary bladder cancer	1.54e-05	0.000381	CcSEcCtD
Azacitidine—Arthralgia—Methotrexate—urinary bladder cancer	1.54e-05	0.000381	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	1.53e-05	0.000379	CcSEcCtD
Azacitidine—Malaise—Epirubicin—urinary bladder cancer	1.53e-05	0.000378	CcSEcCtD
Azacitidine—Discomfort—Methotrexate—urinary bladder cancer	1.52e-05	0.000377	CcSEcCtD
Azacitidine—CDA—Metabolism—PPARG—urinary bladder cancer	1.52e-05	0.000698	CbGpPWpGaD
Azacitidine—Syncope—Epirubicin—urinary bladder cancer	1.52e-05	0.000376	CcSEcCtD
Azacitidine—Leukopenia—Epirubicin—urinary bladder cancer	1.51e-05	0.000375	CcSEcCtD
Azacitidine—Back pain—Doxorubicin—urinary bladder cancer	1.51e-05	0.000375	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—ESR1—urinary bladder cancer	1.51e-05	0.000693	CbGpPWpGaD
Azacitidine—Muscle spasms—Doxorubicin—urinary bladder cancer	1.51e-05	0.000373	CcSEcCtD
Azacitidine—Confusional state—Methotrexate—urinary bladder cancer	1.49e-05	0.000369	CcSEcCtD
Azacitidine—Loss of consciousness—Epirubicin—urinary bladder cancer	1.49e-05	0.000369	CcSEcCtD
Azacitidine—Cough—Epirubicin—urinary bladder cancer	1.48e-05	0.000366	CcSEcCtD
Azacitidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	1.48e-05	0.000366	CcSEcCtD
Azacitidine—Convulsion—Epirubicin—urinary bladder cancer	1.47e-05	0.000363	CcSEcCtD
Azacitidine—Infection—Methotrexate—urinary bladder cancer	1.47e-05	0.000363	CcSEcCtD
Azacitidine—Nausea—Etoposide—urinary bladder cancer	1.46e-05	0.000363	CcSEcCtD
Azacitidine—Hypertension—Epirubicin—urinary bladder cancer	1.46e-05	0.000362	CcSEcCtD
Azacitidine—CDA—Metabolism—CREBBP—urinary bladder cancer	1.46e-05	0.000671	CbGpPWpGaD
Azacitidine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	1.45e-05	0.00036	CcSEcCtD
Azacitidine—Nervous system disorder—Methotrexate—urinary bladder cancer	1.45e-05	0.000359	CcSEcCtD
Azacitidine—Anaemia—Doxorubicin—urinary bladder cancer	1.45e-05	0.000359	CcSEcCtD
Azacitidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	1.45e-05	0.000358	CcSEcCtD
Azacitidine—Myalgia—Epirubicin—urinary bladder cancer	1.44e-05	0.000357	CcSEcCtD
Azacitidine—Arthralgia—Epirubicin—urinary bladder cancer	1.44e-05	0.000357	CcSEcCtD
Azacitidine—Chest pain—Epirubicin—urinary bladder cancer	1.44e-05	0.000357	CcSEcCtD
Azacitidine—Anxiety—Epirubicin—urinary bladder cancer	1.44e-05	0.000356	CcSEcCtD
Azacitidine—Skin disorder—Methotrexate—urinary bladder cancer	1.43e-05	0.000355	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	1.43e-05	0.000355	CcSEcCtD
Azacitidine—Hyperhidrosis—Methotrexate—urinary bladder cancer	1.43e-05	0.000354	CcSEcCtD
Azacitidine—Discomfort—Epirubicin—urinary bladder cancer	1.42e-05	0.000353	CcSEcCtD
Azacitidine—Malaise—Doxorubicin—urinary bladder cancer	1.41e-05	0.00035	CcSEcCtD
Azacitidine—Anorexia—Methotrexate—urinary bladder cancer	1.41e-05	0.000349	CcSEcCtD
Azacitidine—Syncope—Doxorubicin—urinary bladder cancer	1.4e-05	0.000348	CcSEcCtD
Azacitidine—Leukopenia—Doxorubicin—urinary bladder cancer	1.4e-05	0.000347	CcSEcCtD
Azacitidine—Confusional state—Epirubicin—urinary bladder cancer	1.39e-05	0.000345	CcSEcCtD
Azacitidine—Oedema—Epirubicin—urinary bladder cancer	1.38e-05	0.000342	CcSEcCtD
Azacitidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	1.38e-05	0.000342	CcSEcCtD
Azacitidine—Hypotension—Methotrexate—urinary bladder cancer	1.38e-05	0.000342	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—PPARG—urinary bladder cancer	1.38e-05	0.000633	CbGpPWpGaD
Azacitidine—Loss of consciousness—Doxorubicin—urinary bladder cancer	1.38e-05	0.000341	CcSEcCtD
Azacitidine—Infection—Epirubicin—urinary bladder cancer	1.37e-05	0.00034	CcSEcCtD
Azacitidine—Cough—Doxorubicin—urinary bladder cancer	1.37e-05	0.000339	CcSEcCtD
Azacitidine—Shock—Epirubicin—urinary bladder cancer	1.36e-05	0.000337	CcSEcCtD
Azacitidine—Convulsion—Doxorubicin—urinary bladder cancer	1.36e-05	0.000336	CcSEcCtD
Azacitidine—Nervous system disorder—Epirubicin—urinary bladder cancer	1.35e-05	0.000336	CcSEcCtD
Azacitidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	1.35e-05	0.000335	CcSEcCtD
Azacitidine—Hypertension—Doxorubicin—urinary bladder cancer	1.35e-05	0.000335	CcSEcCtD
Azacitidine—Tachycardia—Epirubicin—urinary bladder cancer	1.35e-05	0.000334	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	1.34e-05	0.000333	CcSEcCtD
Azacitidine—Skin disorder—Epirubicin—urinary bladder cancer	1.34e-05	0.000332	CcSEcCtD
Azacitidine—Hyperhidrosis—Epirubicin—urinary bladder cancer	1.34e-05	0.000331	CcSEcCtD
Azacitidine—Insomnia—Methotrexate—urinary bladder cancer	1.33e-05	0.000331	CcSEcCtD
Azacitidine—Chest pain—Doxorubicin—urinary bladder cancer	1.33e-05	0.00033	CcSEcCtD
Azacitidine—Arthralgia—Doxorubicin—urinary bladder cancer	1.33e-05	0.00033	CcSEcCtD
Azacitidine—Myalgia—Doxorubicin—urinary bladder cancer	1.33e-05	0.00033	CcSEcCtD
Azacitidine—Anxiety—Doxorubicin—urinary bladder cancer	1.33e-05	0.000329	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	1.32e-05	0.000328	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—CREBBP—urinary bladder cancer	1.32e-05	0.000608	CbGpPWpGaD
Azacitidine—Discomfort—Doxorubicin—urinary bladder cancer	1.32e-05	0.000326	CcSEcCtD
Azacitidine—Anorexia—Epirubicin—urinary bladder cancer	1.32e-05	0.000326	CcSEcCtD
Azacitidine—Dyspnoea—Methotrexate—urinary bladder cancer	1.32e-05	0.000326	CcSEcCtD
Azacitidine—Dyspepsia—Methotrexate—urinary bladder cancer	1.3e-05	0.000322	CcSEcCtD
Azacitidine—Hypotension—Epirubicin—urinary bladder cancer	1.29e-05	0.00032	CcSEcCtD
Azacitidine—Confusional state—Doxorubicin—urinary bladder cancer	1.29e-05	0.000319	CcSEcCtD
Azacitidine—Decreased appetite—Methotrexate—urinary bladder cancer	1.28e-05	0.000318	CcSEcCtD
Azacitidine—Oedema—Doxorubicin—urinary bladder cancer	1.28e-05	0.000317	CcSEcCtD
Azacitidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	1.28e-05	0.000317	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	1.27e-05	0.000316	CcSEcCtD
Azacitidine—Fatigue—Methotrexate—urinary bladder cancer	1.27e-05	0.000315	CcSEcCtD
Azacitidine—Infection—Doxorubicin—urinary bladder cancer	1.27e-05	0.000315	CcSEcCtD
Azacitidine—Pain—Methotrexate—urinary bladder cancer	1.26e-05	0.000313	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	1.26e-05	0.000312	CcSEcCtD
Azacitidine—Shock—Doxorubicin—urinary bladder cancer	1.26e-05	0.000312	CcSEcCtD
Azacitidine—Nervous system disorder—Doxorubicin—urinary bladder cancer	1.25e-05	0.000311	CcSEcCtD
Azacitidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	1.25e-05	0.00031	CcSEcCtD
Azacitidine—Insomnia—Epirubicin—urinary bladder cancer	1.25e-05	0.00031	CcSEcCtD
Azacitidine—Tachycardia—Doxorubicin—urinary bladder cancer	1.25e-05	0.000309	CcSEcCtD
Azacitidine—Skin disorder—Doxorubicin—urinary bladder cancer	1.24e-05	0.000308	CcSEcCtD
Azacitidine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	1.24e-05	0.000306	CcSEcCtD
Azacitidine—Dyspnoea—Epirubicin—urinary bladder cancer	1.23e-05	0.000305	CcSEcCtD
Azacitidine—Anorexia—Doxorubicin—urinary bladder cancer	1.22e-05	0.000302	CcSEcCtD
Azacitidine—Feeling abnormal—Methotrexate—urinary bladder cancer	1.22e-05	0.000301	CcSEcCtD
Azacitidine—Dyspepsia—Epirubicin—urinary bladder cancer	1.22e-05	0.000301	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	1.21e-05	0.000299	CcSEcCtD
Azacitidine—Decreased appetite—Epirubicin—urinary bladder cancer	1.2e-05	0.000297	CcSEcCtD
Azacitidine—CDA—Metabolism—PTGS2—urinary bladder cancer	1.2e-05	0.000549	CbGpPWpGaD
Azacitidine—Hypotension—Doxorubicin—urinary bladder cancer	1.19e-05	0.000296	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	1.19e-05	0.000295	CcSEcCtD
Azacitidine—Fatigue—Epirubicin—urinary bladder cancer	1.19e-05	0.000295	CcSEcCtD
Azacitidine—Constipation—Epirubicin—urinary bladder cancer	1.18e-05	0.000293	CcSEcCtD
Azacitidine—Pain—Epirubicin—urinary bladder cancer	1.18e-05	0.000293	CcSEcCtD
Azacitidine—Urticaria—Methotrexate—urinary bladder cancer	1.17e-05	0.00029	CcSEcCtD
Azacitidine—Abdominal pain—Methotrexate—urinary bladder cancer	1.17e-05	0.000289	CcSEcCtD
Azacitidine—Body temperature increased—Methotrexate—urinary bladder cancer	1.17e-05	0.000289	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	1.16e-05	0.000288	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—MYC—urinary bladder cancer	1.16e-05	0.000534	CbGpPWpGaD
Azacitidine—Insomnia—Doxorubicin—urinary bladder cancer	1.16e-05	0.000286	CcSEcCtD
Azacitidine—Dyspnoea—Doxorubicin—urinary bladder cancer	1.14e-05	0.000282	CcSEcCtD
Azacitidine—Feeling abnormal—Epirubicin—urinary bladder cancer	1.14e-05	0.000282	CcSEcCtD
Azacitidine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	1.13e-05	0.00028	CcSEcCtD
Azacitidine—Dyspepsia—Doxorubicin—urinary bladder cancer	1.13e-05	0.000279	CcSEcCtD
Azacitidine—Decreased appetite—Doxorubicin—urinary bladder cancer	1.11e-05	0.000275	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	1.1e-05	0.000273	CcSEcCtD
Azacitidine—Fatigue—Doxorubicin—urinary bladder cancer	1.1e-05	0.000273	CcSEcCtD
Azacitidine—Urticaria—Epirubicin—urinary bladder cancer	1.1e-05	0.000272	CcSEcCtD
Azacitidine—Pain—Doxorubicin—urinary bladder cancer	1.09e-05	0.000271	CcSEcCtD
Azacitidine—Constipation—Doxorubicin—urinary bladder cancer	1.09e-05	0.000271	CcSEcCtD
Azacitidine—Abdominal pain—Epirubicin—urinary bladder cancer	1.09e-05	0.000271	CcSEcCtD
Azacitidine—Body temperature increased—Epirubicin—urinary bladder cancer	1.09e-05	0.000271	CcSEcCtD
Azacitidine—Hypersensitivity—Methotrexate—urinary bladder cancer	1.09e-05	0.000269	CcSEcCtD
Azacitidine—Asthenia—Methotrexate—urinary bladder cancer	1.06e-05	0.000262	CcSEcCtD
Azacitidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	1.05e-05	0.000261	CcSEcCtD
Azacitidine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	1.05e-05	0.000259	CcSEcCtD
Azacitidine—Pruritus—Methotrexate—urinary bladder cancer	1.04e-05	0.000259	CcSEcCtD
Azacitidine—CDA—Metabolism—PTEN—urinary bladder cancer	1.04e-05	0.000479	CbGpPWpGaD
Azacitidine—Hypersensitivity—Epirubicin—urinary bladder cancer	1.02e-05	0.000252	CcSEcCtD
Azacitidine—Urticaria—Doxorubicin—urinary bladder cancer	1.02e-05	0.000252	CcSEcCtD
Azacitidine—Abdominal pain—Doxorubicin—urinary bladder cancer	1.01e-05	0.00025	CcSEcCtD
Azacitidine—Body temperature increased—Doxorubicin—urinary bladder cancer	1.01e-05	0.00025	CcSEcCtD
Azacitidine—Diarrhoea—Methotrexate—urinary bladder cancer	1.01e-05	0.00025	CcSEcCtD
Azacitidine—CDA—Metabolism—EP300—urinary bladder cancer	9.95e-06	0.000457	CbGpPWpGaD
Azacitidine—Asthenia—Epirubicin—urinary bladder cancer	9.91e-06	0.000246	CcSEcCtD
Azacitidine—Pruritus—Epirubicin—urinary bladder cancer	9.77e-06	0.000242	CcSEcCtD
Azacitidine—Dizziness—Methotrexate—urinary bladder cancer	9.76e-06	0.000242	CcSEcCtD
Azacitidine—Diarrhoea—Epirubicin—urinary bladder cancer	9.45e-06	0.000234	CcSEcCtD
Azacitidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.42e-06	0.000233	CcSEcCtD
Azacitidine—Vomiting—Methotrexate—urinary bladder cancer	9.38e-06	0.000233	CcSEcCtD
Azacitidine—Rash—Methotrexate—urinary bladder cancer	9.31e-06	0.000231	CcSEcCtD
Azacitidine—Dermatitis—Methotrexate—urinary bladder cancer	9.3e-06	0.00023	CcSEcCtD
Azacitidine—Headache—Methotrexate—urinary bladder cancer	9.25e-06	0.000229	CcSEcCtD
Azacitidine—Asthenia—Doxorubicin—urinary bladder cancer	9.17e-06	0.000227	CcSEcCtD
Azacitidine—Dizziness—Epirubicin—urinary bladder cancer	9.13e-06	0.000226	CcSEcCtD
Azacitidine—Pruritus—Doxorubicin—urinary bladder cancer	9.04e-06	0.000224	CcSEcCtD
Azacitidine—Vomiting—Epirubicin—urinary bladder cancer	8.78e-06	0.000218	CcSEcCtD
Azacitidine—Nausea—Methotrexate—urinary bladder cancer	8.77e-06	0.000217	CcSEcCtD
Azacitidine—Diarrhoea—Doxorubicin—urinary bladder cancer	8.74e-06	0.000217	CcSEcCtD
Azacitidine—Rash—Epirubicin—urinary bladder cancer	8.71e-06	0.000216	CcSEcCtD
Azacitidine—Dermatitis—Epirubicin—urinary bladder cancer	8.7e-06	0.000216	CcSEcCtD
Azacitidine—Headache—Epirubicin—urinary bladder cancer	8.65e-06	0.000214	CcSEcCtD
Azacitidine—Dizziness—Doxorubicin—urinary bladder cancer	8.45e-06	0.000209	CcSEcCtD
Azacitidine—Nausea—Epirubicin—urinary bladder cancer	8.2e-06	0.000203	CcSEcCtD
Azacitidine—Vomiting—Doxorubicin—urinary bladder cancer	8.13e-06	0.000201	CcSEcCtD
Azacitidine—Rash—Doxorubicin—urinary bladder cancer	8.06e-06	0.0002	CcSEcCtD
Azacitidine—Dermatitis—Doxorubicin—urinary bladder cancer	8.05e-06	0.000199	CcSEcCtD
Azacitidine—Headache—Doxorubicin—urinary bladder cancer	8.01e-06	0.000198	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—MYC—urinary bladder cancer	7.86e-06	0.000361	CbGpPWpGaD
Azacitidine—Nausea—Doxorubicin—urinary bladder cancer	7.59e-06	0.000188	CcSEcCtD
